ENBREL Trademark

Trademark Overview

On Thursday, October 17, 1996, a trademark application was filed for ENBREL with the United States Patent and Trademark Office. The USPTO has given the ENBREL trademark a serial number of 75183260. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, December 22, 2018. This trademark is owned by IMMUNEX CORPORATION. The ENBREL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for treating human immune diseases and conditions
enbrel

General Information

Serial Number75183260
Word MarkENBREL
Filing DateThursday, October 17, 1996
Status800 - REGISTERED AND RENEWED
Status DateSaturday, December 22, 2018
Registration Number2220795
Registration DateTuesday, January 26, 1999
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 27, 1998

Trademark Statements

Goods and Servicespharmaceutical preparations for treating human immune diseases and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 7, 1996
Primary Code005
First Use Anywhere DateMonday, August 24, 1998
First Use In Commerce DateMonday, August 24, 1998

Trademark Owner History

Party NameIMMUNEX CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameIMMUNEX CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101
Party NameIMMUNEX CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98101

Trademark Events

Event DateEvent Description
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 22, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, December 22, 2018REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Saturday, December 22, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, December 22, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 10, 2018TEAS SECTION 8 & 9 RECEIVED
Thursday, August 2, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 2, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 26, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, March 17, 2009REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, March 17, 2009REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, March 2, 2009ASSIGNED TO PARALEGAL
Monday, January 5, 2009TEAS SECTION 8 & 9 RECEIVED
Saturday, February 12, 2005REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, January 26, 2005REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Wednesday, January 26, 2005TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 26, 1999REGISTERED-PRINCIPAL REGISTER
Wednesday, November 18, 1998ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 17, 1998ASSIGNED TO EXAMINER
Thursday, November 12, 1998STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 21, 1998USE AMENDMENT FILED
Tuesday, April 21, 1998NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 27, 1998PUBLISHED FOR OPPOSITION
Friday, December 26, 1997NOTICE OF PUBLICATION
Wednesday, November 26, 1997APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 24, 1997EXAMINER'S AMENDMENT MAILED
Monday, April 28, 1997NON-FINAL ACTION MAILED
Thursday, April 24, 1997ASSIGNED TO EXAMINER

Related Keywords

enbrel diseases conditions immune human preparations treating pharmaceutical